Latest News

ToxStrategies scientists publish pre-clinical toxicity studies on cannabidiol (CBD)

ToxStrategies scientists have published two manuscripts in Food and Chemical Toxicology reporting the study design and outcome of 14- and 90-day repeat-dose oral toxicity studies and a reproductive toxicity study conducted on a purified, hemp-derived CBD isolate. These are the first OECD guideline-compliant toxicity studies on CBD to be published. As such, they fill an important research gap in publicly available data on the safety profile of CBD, providing key data to support its safe use by consumers in foods and dietary supplements. Led by Dr. Rayetta Henderson, ToxStrategies coauthors included Dr. Melissa Heintz, Dr. John Rogers, and Dr. Susan Borghoff.